January 21st 2019
Antisense Phase II Clinical Trial now 50% enrolled and on track for completion
November 22nd 2018
ANP: Why partnering with big biotech has its benefits
October 24th 2018
Breakthrough Prize given to Antisense pioneer
October 22nd 2018
Biotech surges & pot-stocks reach new highs
October 17th 2018
Antisense rally prompts question: ‘Are ASX Biotechs back?’
October 4th 2018
Antisense Therapeutics could fill Duchenne Muscular Dystrophy treatment gap
Connect with us
Subscribe to our weekly wrap.
Thanks for subscribing!
